Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Agile Therapeutics Inc. AGRX

Alternate Symbol(s):  AGXRW

Agile Therapeutics Inc is a women's healthcare company to fulfill the unmet health needs of women. Its product candidates are designed to provide women with contraceptive options. The firm's initial product, Twirla, (levonorgestrel and ethinyl estradiol) transdermal system is a non-daily prescription contraceptive. Twirla is based on proprietary transdermal patch technology, called Skinfusion, which is designed to allow drug delivery through the skin.


Recent & Breaking News (NDAQ:AGRX)

Agile Therapeutics to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call and Provide Corporate and Twirla Commercial Updates on Wednesday, March 30, 2022

GlobeNewswire March 7, 2022

Agile Therapeutics Acknowledges New Government Guidance Reinforcing Requirement to Cover Contraceptives that a Woman and Her Heathcare Provider Determine are Medically Appropriate at No Cost

GlobeNewswire January 12, 2022

Agile Therapeutics and Afaxys Partner to Expand Access to Twirla® (Levonorgestrel and Ethinyl Estradiol) Transdermal System

GlobeNewswire January 10, 2022

Agile Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference

GlobeNewswire January 5, 2022

Agile Therapeutics to Present at the Biotech Showcase and H.C. Wainwright BioConnect Virtual Conferences

GlobeNewswire January 5, 2022

Agile Therapeutics Reports Third Quarter 2021 Financial Results

GlobeNewswire November 2, 2021

Agile Therapeutics to Report Third Quarter 2021 Financial Results and Provide Business Update on Tuesday, November 2, 2021

GlobeNewswire October 22, 2021

Agile Therapeutics Applauds Congressional Chairs' Letter to Biden Administration Requesting Enforcement of Contraceptive Access Under Affordable Care Act

GlobeNewswire October 12, 2021

Agile Therapeutics Appoints Josephine Torrente to its Board of Directors

GlobeNewswire October 8, 2021

Agile Therapeutics Announces Pricing of $22,666,650 Underwritten Public Offering of Common Stock and Warrants

GlobeNewswire October 8, 2021

Agile Therapeutics Announces Proposed Underwritten Public Offering of Common Stock and Warrants

GlobeNewswire October 7, 2021

Agile Therapeutics Announces Addition of Twirla® to a Preferred Drug Position on Medi-Cal Formulary

GlobeNewswire October 4, 2021

Agile Therapeutics Partners with Carli Lloyd, U.S. Women’s Soccer Star and Four-Time Olympian, to Bring Awareness to Women’s Health Topics

TheNewsWire September 28, 2021

Agile Therapeutics Partners with Carli Lloyd, U.S. Women's Soccer Star and Four-Time Olympian, to Bring Awareness to Women's Health Topics

GlobeNewswire September 28, 2021

Agile Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire September 7, 2021

Agile Therapeutics Partners with Telehealth Service, Pandia Health, to Increase Women's Access to Twirla® (levonorgestrel and ethinyl estradiol) transdermal system

GlobeNewswire August 20, 2021

Agile Therapeutics Reports Second Quarter 2021 Financial Results

GlobeNewswire July 26, 2021

50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021

Accesswire July 8, 2021

Agile Therapeutics to Report Second Quarter 2021 Financial Results and Provide Business Update on Monday, July 26, 2021

GlobeNewswire July 1, 2021

50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021

Accesswire June 23, 2021